Healthpeak Properties, Inc. — Cyborg Score 5/10

Mixed
Healthcare Real Estate Investment Trust (REIT)

Strategic Profile

Healthpeak Properties has concentrated exposure to South San Francisco life-science assets, allowing it to benefit from the region's innovation-led recovery. Healthpeak enjoys industry tailwinds, including an aging population and regulatory changes that expand the pool of participants in the healthcare system. However, Healthpeak's new management team doesn't have the same operational experience or relationships as its peers, which could make it difficult to achieve the same internal growth.

Cyborg Score Rationale

Healthpeak Properties is deeply undervalued, trading at just 9.1x forward P/FFO and offering a 7.3% dividend yield. ROIC of 2.76% is in the bottom 25% of its industry. Management execution risk exists despite strong fundamentals in core asset classes.

Top Insights

  • Trading at significant valuation discount with compelling 7.3% dividend yield, suggesting market skepticism on management execution
  • Life science and outpatient medical portfolio benefits from structural healthcare trends but facing near-term oversupply headwinds in lab assets
  • Q4 2025 same-store NOI growth of 3.9% with FFO of $0.47/share demonstrates stable underlying operations despite stock underperformance
  • New management team lacks operational relationships of peers, creating execution risk on capital recycling plan of $1B+ portfolio optimization

Named Competitors

  • Welltower — Senior housing and medical office REIT
  • Medical Properties Trust — Hospital and healthcare facility REIT
  • Omega Healthcare — Senior housing and skilled nursing REIT
  • Sabra Health Care REIT — Senior housing and skilled nursing REIT

Recent Developments

  • (February 2026) Q4 2025 earnings beat with FFO of $0.47 per share, issued FY 2026 EPS guidance of $1.70-$1.74
  • (February 2026) Stock declined 7.1% despite beating earnings, revealing investor concerns about capital allocation and past performance
  • (January 2026) Goldman Sachs initiated coverage with neutral rating and $17.00 price target
  • (January 2026) Weiss Ratings upgraded from sell to hold rating, signaling modest improvement in sentiment

Open the full interactive Healthpeak Properties, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →